Sacituzumab Govitecan Plus Pembrolizumab Shows Promise for Bladder Sparing in Muscle-Invasive Cancer
Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant ...
Induction Yervoy (ipilimumab) plus Opdivo (nivolumab) followed by consolidative chemoradiotherapy demonstrated bladder ...
KEYNOTE-B15 compared perioperative enfortumab vedotin plus pembrolizumab against neoadjuvant cisplatin-based chemotherapy in cisplatin-eligible MIBC, using event-free survival as the primary endpoint.
Graphical comparison of bladder augmentation surgery using either ileum (top) or a cell-seeded, biodegradable scaffold (bottom). MSCs and HSPCs represent different types of stem cells found in the ...
It’s safe to assume that most people don’t associate Botox with overactive bladders, but doctors who use it to treat just a sliver of the 33 million people in the U.S. struggling with uncontrollable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results